Episurf Medical received CE Mark approval for the Epioscopy™ Damage Assessment Tool, designed to support 3D visualization of knee segments, visual marking of chondral and osteochondral lesions in the femoral knee and a written assessment of structural deviations on the tibia, patella, meniscus and ACL.
A visualization of the implant/guide is added to the 3D image of the knee, if Episurf’s implant is chosen for the cartilage repair procedure.
This marks Episurf Medical’s fifth product on the market. The company is focused upon early intervention to treat osteoarthritis via minimally invasive, patient-specific methods, using:
Episealer® personalized implants and Epiguide® surgical drill guides
The μiFidelity® IT platform to support the design of implants that are tailored to each individual’s injury
Episurf Medical received CE Mark approval for the Epioscopy™ Damage Assessment Tool, designed to support 3D visualization of knee segments, visual marking of chondral and osteochondral lesions in the femoral knee and a written assessment of structural deviations on the tibia, patella, meniscus and ACL.
A visualization of the implant/guide is...
Episurf Medical received CE Mark approval for the Epioscopy™ Damage Assessment Tool, designed to support 3D visualization of knee segments, visual marking of chondral and osteochondral lesions in the femoral knee and a written assessment of structural deviations on the tibia, patella, meniscus and ACL.
A visualization of the implant/guide is added to the 3D image of the knee, if Episurf’s implant is chosen for the cartilage repair procedure.
This marks Episurf Medical’s fifth product on the market. The company is focused upon early intervention to treat osteoarthritis via minimally invasive, patient-specific methods, using:
Episealer® personalized implants and Epiguide® surgical drill guides
The μiFidelity® IT platform to support the design of implants that are tailored to each individual’s injury
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
